Key points are not available for this paper at this time.
Abstract Background Legacy‐oriented interventions have the potential to offer pediatric oncology patients and families comfort at end of life and during bereavement. Certified child life specialists often provide these services, and presently little is known about whether disparities exist in the provision of legacy‐oriented interventions. Methods In this retrospective decedent cohort study, we examined demographic and clinical characteristics from a sample of 678 pediatric oncology patients who died between 2015 and 2019. Bivariate analysis assessed differences between patients who received any versus no legacy‐oriented intervention. Uni‐ and multivariable logistic regression models assessed associations of baseline characteristics and likelihood of receiving legacy‐oriented intervention. Further multivariable analysis explored joint effects of significant variables identified in the univariable analysis. Results Fifty‐two percent of patients received a legacy‐oriented intervention. Older adolescents (≥13 years) were less likely (odds ratio OR: 1.73, p = .007) to receive legacy‐oriented interventions than younger ones. Patients with home/hospice deaths were also less likely (OR: 19.98, p < .001) to receive interventions compared to patients who passed away at SJCRH locations. Hispanic patients (OR: 1.53, p = .038) and those in palliative care (OR: 10.51, p < .001) were more likely to receive interventions. No significant race association was noted. Conclusion All children and adolescents with cancer deserve quality care at end of life, including access to legacy‐oriented interventions, yet nearly half of patients in this cohort did not receive these services. By identifying demographic and clinical characteristics associated with decreased odds of receiving legacy‐oriented interventions, healthcare professionals can modify end‐of‐life care processes to improve access. Introducing legacy‐oriented interventions early and increasing exposure in community spaces may enhance access to legacy‐oriented interventions for pediatric oncology patients.
Daniels et al. (Thu,) studied this question.